SE0100569D0 - New compounds - Google Patents

New compounds

Info

Publication number: SE0100569D0
Authority: SE; Sweden
Prior art keywords: new compounds; active compounds; preparation; compounds; new
Prior art date: 2001-02-20

Application number

SE0100569A

Other languages

English (en)

Swedish (sv)

Inventor

Stefan Berg

Sven Hellberg

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-20

Filing date

2001-02-20

Publication date

2001-02-20

2001-02-20 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2001-02-20 Priority to SE0100569A priority Critical patent/SE0100569D0/xx

2001-02-20 Publication of SE0100569D0 publication Critical patent/SE0100569D0/xx

2002-02-18 Priority to NZ526783A priority patent/NZ526783A/en

2002-02-18 Priority to JP2002565540A priority patent/JP4475869B2/ja

2002-02-18 Priority to SK1025-2003A priority patent/SK10252003A3/sk

2002-02-18 Priority to CNB028052471A priority patent/CN1294131C/zh

2002-02-18 Priority to US10/468,604 priority patent/US7345050B2/en

2002-02-18 Priority to BR0206935-0A priority patent/BR0206935A/pt

2002-02-18 Priority to HK05102865.3A priority patent/HK1070071B/xx

2002-02-18 Priority to PL02363393A priority patent/PL363393A1/xx

2002-02-18 Priority to IL15678102A priority patent/IL156781A0/xx

2002-02-18 Priority to RU2003121307/04A priority patent/RU2003121307A/ru

2002-02-18 Priority to EEP200300400A priority patent/EE200300400A/xx

2002-02-18 Priority to PCT/SE2002/000271 priority patent/WO2002065979A2/en

2002-02-18 Priority to EP02711620A priority patent/EP1373266A2/en

2002-02-18 Priority to CZ20032235A priority patent/CZ20032235A3/cs

2002-02-18 Priority to KR10-2003-7010874A priority patent/KR20030084935A/ko

2002-02-18 Priority to MXPA03007320A priority patent/MXPA03007320A/es

2002-02-18 Priority to HU0303254A priority patent/HUP0303254A2/hu

2002-02-18 Priority to CA002434648A priority patent/CA2434648A1/en

2003-07-08 Priority to IS6868A priority patent/IS6868A/is

2003-08-07 Priority to BG108070A priority patent/BG108070A/bg

2003-08-08 Priority to ZA200306171A priority patent/ZA200306171B/xx

2003-08-19 Priority to NO20033679A priority patent/NO20033679L/no

Links

150000001875 compounds Chemical class 0.000 title abstract 5
239000000543 intermediate Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Reproductive Health (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Virology (AREA)
Oncology (AREA)
Obesity (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Communicable Diseases (AREA)
Hospice & Palliative Care (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Dermatology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SE0100569A 2001-02-20 2001-02-20 New compounds SE0100569D0 (sv)

Priority Applications (23)

Application Number	Priority Date	Filing Date	Title
SE0100569A SE0100569D0 (sv)	2001-02-20	2001-02-20	New compounds
CA002434648A CA2434648A1 (en)	2001-02-20	2002-02-18	(diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
RU2003121307/04A RU2003121307A (ru)	2001-02-20	2002-02-18	(диазоло-пиридинил)-пиримидины для применения в лечении нарушений центральной нервной системы и диабета
PCT/SE2002/000271 WO2002065979A2 (en)	2001-02-20	2002-02-18	(diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
SK1025-2003A SK10252003A3 (sk)	2001-02-20	2002-02-18	Pyrimidínové zlúčeniny
CNB028052471A CN1294131C (zh)	2001-02-20	2002-02-18	新嘧啶化合物
US10/468,604 US7345050B2 (en)	2001-02-20	2002-02-18	Pyrimidine compounds
BR0206935-0A BR0206935A (pt)	2001-02-20	2002-02-18	Composto, formulação farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de condições associadas com a inibição da glicogênio sintase quinase-3, e, processo para a preparação de um composto
HK05102865.3A HK1070071B (en)	2001-02-20	2002-02-18	New pyrimidine compounds
PL02363393A PL363393A1 (en)	2001-02-20	2002-02-18	New pyrimidine compounds
IL15678102A IL156781A0 (en)	2001-02-20	2002-02-18	(diazolo-pyridinyl)-pyrimidines for use in teatment of cns disorders and diabetes
NZ526783A NZ526783A (en)	2001-02-20	2002-02-18	(Diazolo-pyridinyl)-pyrimidines for use in treatment of CNS disorders and diabetes
EEP200300400A EE200300400A (et)	2001-02-20	2002-02-18	Pürimidiiniühendid, nende valmistamismeetod ning kasutamine
JP2002565540A JP4475869B2 (ja)	2001-02-20	2002-02-18	新規なピリミジン化合物
EP02711620A EP1373266A2 (en)	2001-02-20	2002-02-18	(diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
CZ20032235A CZ20032235A3 (cs)	2001-02-20	2002-02-18	Nové pyrimidinové sloučeniny
KR10-2003-7010874A KR20030084935A (ko)	2001-02-20	2002-02-18	Ｃｎｓ 장애 및 당뇨병의 치료에 사용하기 위한(디아졸로-피리디닐)-피리미딘
MXPA03007320A MXPA03007320A (es)	2001-02-20	2002-02-18	Nuevos compuestos de pirimidina.
HU0303254A HUP0303254A2 (hu)	2001-02-20	2002-02-18	Új pirimidinvegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
IS6868A IS6868A (is)	2001-02-20	2003-07-08	Ný pýrimidínefnasambönd
BG108070A BG108070A (bg)	2001-02-20	2003-08-07	Нови пиримидинови съединения
ZA200306171A ZA200306171B (en)	2001-02-20	2003-08-08	(Diazolo-pyridinyl)-pyrimidines for use in treatment of CNS disorders and diabetes.
NO20033679A NO20033679L (no)	2001-02-20	2003-08-19	Nye pyrimidinforbindelser

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0100569A SE0100569D0 (sv)	2001-02-20	2001-02-20	New compounds

Publications (1)

Publication Number	Publication Date
SE0100569D0 true SE0100569D0 (sv)	2001-02-20

Family

ID=20283059

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE0100569A SE0100569D0 (sv)	2001-02-20	2001-02-20	New compounds

Country Status (22)

Country	Link
US (1)	US7345050B2 (cs)
EP (1)	EP1373266A2 (cs)
JP (1)	JP4475869B2 (cs)
KR (1)	KR20030084935A (cs)
CN (1)	CN1294131C (cs)
BG (1)	BG108070A (cs)
BR (1)	BR0206935A (cs)
CA (1)	CA2434648A1 (cs)
CZ (1)	CZ20032235A3 (cs)
EE (1)	EE200300400A (cs)
HU (1)	HUP0303254A2 (cs)
IL (1)	IL156781A0 (cs)
IS (1)	IS6868A (cs)
MX (1)	MXPA03007320A (cs)
NO (1)	NO20033679L (cs)
NZ (1)	NZ526783A (cs)
PL (1)	PL363393A1 (cs)
RU (1)	RU2003121307A (cs)
SE (1)	SE0100569D0 (cs)
SK (1)	SK10252003A3 (cs)
WO (1)	WO2002065979A2 (cs)
ZA (1)	ZA200306171B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0205688D0 (en)	2002-03-09	2002-04-24	Astrazeneca Ab	Chemical compounds
GB0205690D0 (en)	2002-03-09	2002-04-24	Astrazeneca Ab	Chemical compounds
GB0205693D0 (en)	2002-03-09	2002-04-24	Astrazeneca Ab	Chemical compounds
JP2005524672A (ja)	2002-03-09	2005-08-18	アストラゼネカアクチボラグ	Ｃｄｋ阻害活性を有するイミダゾリル置換ピリミジン誘導体
GB0226583D0 (en) *	2002-11-14	2002-12-18	Cyclacel Ltd	Compounds
GB0311276D0 (en)	2003-05-16	2003-06-18	Astrazeneca Ab	Chemical compounds
GB0311274D0 (en)	2003-05-16	2003-06-18	Astrazeneca Ab	Chemical compounds
TW200528101A (en)	2004-02-03	2005-09-01	Astrazeneca Ab	Chemical compounds
US20080207594A1 (en)	2005-05-04	2008-08-28	Davelogen Aktiengesellschaft	Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders
CN101321531A (zh) *	2005-10-03	2008-12-10	阿斯利康(瑞典)有限公司	嘧啶衍生物在制备用于预防和/或治疗阿尔茨海默病的药物中的用途
AR058073A1 (es) *	2005-10-03	2008-01-23	Astrazeneca Ab	Derivados de imidazol 5-il-pirimidina, procesos de obtencion, composiciones farmaceuticas y usos
CA2755268C (en)	2005-11-15	2013-12-31	Array Biopharma, Inc.	Erbb inhibitors
TW200811169A (en) *	2006-05-26	2008-03-01	Astrazeneca Ab	Chemical compounds
AU2008210455A1 (en) *	2007-01-31	2008-08-07	Vertex Pharmaceuticals Incorporated	2-aminopyridine derivatives useful as kinase inhibitors
TWI580694B (zh)	2007-11-30	2017-05-01	建南德克公司	抗-ｖｅｇｆ抗體
AU2009228765B2 (en) *	2008-03-24	2012-05-31	Novartis Ag	Arylsulfonamide-based matrix metalloprotease inhibitors
NZ602832A (en)	2008-07-14	2014-04-30	Gilead Sciences Inc	Fused heterocyclic hdac inhibitor compounds
AU2009271003A1 (en)	2008-07-14	2010-01-21	Gilead Sciences, Inc.	Imidazolylpyrimidine compounds as HDAC and/or CDK inhibitors
CA2728228A1 (en)	2008-07-14	2010-01-21	Gilead Sciences, Inc.	Oxindolyl inhibitor compounds
AU2009276699A1 (en)	2008-07-28	2010-02-04	Gilead Sciences, Inc.	Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
BRPI0919564A2 (pt)	2008-10-22	2019-09-24	Genentech, Inc	modulação da degeneração do axônio
RU2011140238A (ru)	2009-04-15	2013-05-20	Астразенека Аб	Имидазол-замещенные пиримидины, полезные в лечении заболеваний, ассоциированных с киназой-3 гликогенсинтазы, таких как болезнь альцгеймера
KR20120031170A (ko)	2009-06-08	2012-03-30	길리애드 사이언시즈, 인코포레이티드	알카노일아미노 벤즈아미드 아닐린 ｈｄａｃ 저해제 화합물
ES2463826T3 (es)	2009-06-08	2014-05-29	Gilead Sciences, Inc.	Compuestos inhibidores de HDAC de cicloalquilcarbamato benzamida anilina
KR102414221B1 (ko)	2020-08-04	2022-06-27	서울시립대학교 산학협력단	열전 소자 어셈블리, 이의 제조 방법, 및 이를 포함하는 열전 모듈

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE29032E (en) *	1969-06-12	1976-11-09	Riker Laboratories, Inc.	3-Benzoylfluoro-methanesulfonanilides
FR2179493A1 (en) *	1972-04-10	1973-11-23	Roussel Uclaf	Amino benzhydrols - choleretics anticonvulsants sedatives and barbiturate potentiators
DE3042466A1 (de) *	1980-11-11	1982-06-16	A. Nattermann & Cie GmbH, 5000 Köln	N-substituierte (omega) -(2-oxo-4-imidazolin-l-yl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
TW225528B (cs) *	1992-04-03	1994-06-21	Ciba Geigy Ag
US5521184A (en) *	1992-04-03	1996-05-28	Ciba-Geigy Corporation	Pyrimidine derivatives and processes for the preparation thereof
GB9523675D0 (en)	1995-11-20	1996-01-24	Celltech Therapeutics Ltd	Chemical compounds
GB9701453D0 (en) *	1997-01-24	1997-03-12	Leo Pharm Prod Ltd	Aminobenzophenones
GB9919778D0 (en)	1999-08-21	1999-10-27	Zeneca Ltd	Chemical compounds

2001
- 2001-02-20 SE SE0100569A patent/SE0100569D0/xx unknown
2002
- 2002-02-18 SK SK1025-2003A patent/SK10252003A3/sk unknown
- 2002-02-18 IL IL15678102A patent/IL156781A0/xx unknown
- 2002-02-18 PL PL02363393A patent/PL363393A1/xx not_active Application Discontinuation
- 2002-02-18 CA CA002434648A patent/CA2434648A1/en not_active Abandoned
- 2002-02-18 MX MXPA03007320A patent/MXPA03007320A/es unknown
- 2002-02-18 EP EP02711620A patent/EP1373266A2/en not_active Withdrawn
- 2002-02-18 HU HU0303254A patent/HUP0303254A2/hu unknown
- 2002-02-18 WO PCT/SE2002/000271 patent/WO2002065979A2/en not_active Ceased
- 2002-02-18 CN CNB028052471A patent/CN1294131C/zh not_active Expired - Fee Related
- 2002-02-18 EE EEP200300400A patent/EE200300400A/xx unknown
- 2002-02-18 NZ NZ526783A patent/NZ526783A/en unknown
- 2002-02-18 JP JP2002565540A patent/JP4475869B2/ja not_active Expired - Lifetime
- 2002-02-18 KR KR10-2003-7010874A patent/KR20030084935A/ko not_active Withdrawn
- 2002-02-18 CZ CZ20032235A patent/CZ20032235A3/cs unknown
- 2002-02-18 RU RU2003121307/04A patent/RU2003121307A/ru not_active Application Discontinuation
- 2002-02-18 BR BR0206935-0A patent/BR0206935A/pt not_active IP Right Cessation
- 2002-02-18 US US10/468,604 patent/US7345050B2/en not_active Expired - Fee Related
2003
- 2003-07-08 IS IS6868A patent/IS6868A/is unknown
- 2003-08-07 BG BG108070A patent/BG108070A/bg unknown
- 2003-08-08 ZA ZA200306171A patent/ZA200306171B/xx unknown
- 2003-08-19 NO NO20033679A patent/NO20033679L/no unknown

Also Published As

Publication number	Publication date
NO20033679D0 (no)	2003-08-19
HK1070071A1 (en)	2005-06-10
KR20030084935A (ko)	2003-11-01
CA2434648A1 (en)	2002-08-29
CN1537112A (zh)	2004-10-13
PL363393A1 (en)	2004-11-15
US20040077642A1 (en)	2004-04-22
BR0206935A (pt)	2004-06-29
JP2004527486A (ja)	2004-09-09
JP4475869B2 (ja)	2010-06-09
EE200300400A (et)	2003-12-15
CN1294131C (zh)	2007-01-10
NZ526783A (en)	2005-04-29
HUP0303254A2 (hu)	2004-01-28
WO2002065979A3 (en)	2003-02-20
US7345050B2 (en)	2008-03-18
SK10252003A3 (sk)	2004-02-03
WO2002065979A2 (en)	2002-08-29
EP1373266A2 (en)	2004-01-02
RU2003121307A (ru)	2005-02-27
NO20033679L (no)	2003-08-19
BG108070A (bg)	2004-07-30
ZA200306171B (en)	2004-11-08
CZ20032235A3 (cs)	2004-01-14
IS6868A (is)	2003-07-08
IL156781A0 (en)	2004-02-08
MXPA03007320A (es)	2003-12-04

Publication	Publication Date	Title
SE0200979D0 (sv)	2002-03-28	New compounds
TW200745111A (en)	2007-12-16	New compounds
ATE381537T1 (de)	2008-01-15	Formanilid-derivative als beta2-adrenorezeptor- agonisten
TW200510375A (en)	2005-03-16	New compounds
UY27368A1 (es)	2003-01-31	Nuevos compuestos
SE0102439D0 (sv)	2001-07-05	New compounds
ATE365720T1 (de)	2007-07-15	Agonisten von beta-adrenorezeptoren
BG106095A (bg)	2002-06-28	Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
BR0211473A (pt)	2004-10-26	Novos compostos
EA200300776A1 (ru)	2004-06-24	Производные фенэтаноламина для лечения респираторных заболеваний
MXPA02007942A (es)	2004-09-10	Derivados de pirrolopirimidinona, procesos de preparacion y uso.
GB0003154D0 (en)	2000-04-05	Novel compounds
BR0211472A (pt)	2004-11-09	Novos compostos
NO20024005D0 (no)	2002-08-22	Pteridinforbindelser for behandling av psoriasis
IS6520A (is)	2002-08-22	Ný efnasambönd
SE9904508D0 (sv)	1999-12-09	New compounds
WO2002065979A3 (en)	2003-02-20	(diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes
SE0102440D0 (sv)	2001-07-05	New compound
SE0102055D0 (sv)	2001-06-08	New Compounds
SE0104331D0 (sv)	2001-12-19	Novel compounds
SE0101322D0 (sv)	2001-04-12	Novel compounds
SE0401655D0 (sv)	2004-06-24	New compounds
ATE253359T1 (de)	2003-11-15	Antithrombotische mittel
SE0102057D0 (sv)	2001-06-08	New Salts I
IT1307786B1 (it)	2001-11-19	Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.

SE0100569D0 - New compounds - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (23)

Applications Claiming Priority (1)

Publications (1)

Family

ID=20283059

Family Applications (1)

Country Status (22)

Families Citing this family (25)

Family Cites Families (8)

Also Published As

Similar Documents